Current issues in clinical staging of perihilar cholangiocarcinoma—a European snapshot survey
Clinical Scorecard: Challenges in the Clinical Staging of Perihilar Cholangiocarcinoma: Insights from a European Survey
At a Glance
Category Detail
Condition Perihilar Cholangiocarcinoma (pCCA) Key Mechanisms Multidisciplinary management and complex staging processes Target Population Patients with suspected pCCA Care Setting European medical centers evaluating pCCA
Key Highlights
91% of centers are hospitals offering pCCA surgery 94% of centers have multidisciplinary team (MDT) conferences for patient assessment 53% of centers evaluate transplantation eligibility for unresectable pCCA 76% of centers recommend MRI with liver-specific contrast for localized disease 51% of centers recommend endoscopic biliary drainage as primary intervention Guideline-Based Recommendations
Diagnosis
Use of multiphase CT and MRI for assessment of surgical candidates Consideration of PET-CT in select cases Management
Multidisciplinary team involvement is crucial for patient care Evaluation for transplantation eligibility should be available where applicable Monitoring & Follow-up
Regular assessment through imaging techniques Risks
Challenges in accurate staging may hinder risk stratification and therapy tailoring Patient & Prescribing Data
Patients with suspected pCCA across Europe
Neoadjuvant therapy is commonly used in transplantation programs
Clinical Best Practices
Ensure availability of a comprehensive MDT for pCCA assessment Utilize standardized imaging protocols for diagnosis and staging Facilitate access to transplantation evaluation for eligible patients Related Resources & Content
